Meitheal Pharmaceuticals Inc. is recalling 34,860 vials of Cisatracurium Besylate Injection, USP (10 mg per 5 mL). This recall was initiated because some cartons were found to contain vials mislabeled as Phenylephrine Hydrochloride Injection, USP, even though the vials actually contain Cisatracurium. These products were distributed nationwide in the United States and were sold in cartons containing ten 5 mL single-dose vials.
Cisatracurium is a potent muscle relaxant used during surgery or with breathing machines; if it is mistaken for Phenylephrine (a blood pressure medication) and administered to a patient who is not sedated or being mechanically ventilated, it can cause respiratory failure, permanent airway damage, or death.
Return for refund and healthcare consultation
Image of Incorrect Labeling
Photo of the Mislabeled Product being recalled
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · FDA Press Release · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.